question_key
stringlengths 16
58
| relation
stringlengths 6
48
| question_template
stringlengths 29
90
| subject_cui
stringlengths 8
8
| subject_label
stringlengths 4
160
| correct_object_cui
stringlengths 8
8
| correct_object_label
stringlengths 3
204
| opa
stringlengths 7
150
| opb
stringlengths 3
204
| opc
stringlengths 4
221
| opd
stringlengths 5
166
| cop
int64 0
3
|
|---|---|---|---|---|---|---|---|---|---|---|---|
C5396085::active_ingredient_of
|
active_ingredient_of
|
Which of the following has {subj} as an active ingredient?
|
C5396085
|
Inactivated whole Human poliovirus antigen
|
C5548580
|
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens only vaccine product
|
Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine
|
Acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus and inactivated Human poliovirus antigens only vaccine product
|
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus
|
diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B
| 1 |
C0017628::active_ingredient_of
|
active_ingredient_of
|
Which of the following has {subj} as an active ingredient?
|
C0017628
|
glyburide
|
C0939773
|
glyburide / metformin
|
glyburide / metformin
|
metformin / ropinirole
|
clopamide / reserpine
|
phenformin and sulfonylureas
| 0 |
C0145106::active_ingredient_of
|
active_ingredient_of
|
Which of the following has {subj} as an active ingredient?
|
C0145106
|
teicoplanin
|
C4754944
|
Teicoplanin only product
|
Teicoplanin only product
|
metronidazole / scopolamine
|
bifonazole, combinations
|
fluocinolone acetonide and antibiotics
| 0 |
C0725616::active_moiety_of
|
active_moiety_of
|
Which of the following has {subj} as its active moiety?
|
C0725616
|
citric acid, anhydrous
|
C0376734
|
ACD-A solution
|
Efasin-HD
|
MSP-Blu
|
ACD-A solution
|
E-Z-CAT
| 2 |
C0085149::active_moiety_of
|
active_moiety_of
|
Which of the following has {subj} as its active moiety?
|
C0085149
|
tacrolimus
|
C5221552
|
TACROLIMUS 1 g in 1 g NOT APPLICABLE POWDER
|
HEPARIN SODIUM (BEEF LUNG)
|
FORMALDEHYDE/ISOPROPYL ALCOHOL/SODIUM NITRITE
|
MORPHINE SULFATE PWDR
|
TACROLIMUS 1 g in 1 g NOT APPLICABLE POWDER
| 3 |
C0059374::active_moiety_of
|
active_moiety_of
|
Which of the following has {subj} as its active moiety?
|
C0059374
|
enrofloxacin
|
C4283200
|
ENROFLOXACIN 24.75 kg in 25 kg NOT APPLICABLE POWDER [X]
|
SODIUM CHLORIDE/VINBLASTINE
|
ALLERGENIC EXTRACT, ELM, CHINESE & AMERICAN, POLLEN MIX
|
LANSOPRAZOLE 3MG/ML SUSP,ORAL
|
ENROFLOXACIN 24.75 kg in 25 kg NOT APPLICABLE POWDER [X]
| 3 |
C0448161::anatomic_structure_is_physical_part_of
|
anatomic_structure_is_physical_part_of
|
Which anatomic structure is {subj} physically part of?
|
C0448161
|
Structure of shaft of rib
|
C0037253
|
Skeletal system
|
Axial skeletal system
|
Skeletal system of upper limb
|
Skeletal system.peripheral
|
Skeletal system
| 3 |
C1520699::anatomic_structure_is_physical_part_of
|
anatomic_structure_is_physical_part_of
|
Which anatomic structure is {subj} physically part of?
|
C1520699
|
16q22-q23
|
C1520690
|
16q
|
SCA10 gene.CAG repeats
|
16q
|
End Chromosome Band
|
Chromosome 13 Short Arm
| 1 |
C1520356::anatomic_structure_is_physical_part_of
|
anatomic_structure_is_physical_part_of
|
Which anatomic structure is {subj} physically part of?
|
C1520356
|
11p11.2-p11.1
|
C0007634
|
Cells
|
Stem cells
|
Cells.ZAP70
|
Cells.CD21
|
Cells
| 3 |
C0925420::articulates_with
|
articulates_with
|
Which anatomic structure articulates with {subj}?
|
C0925420
|
Right zygomatic bone
|
C0037884
|
Sphenoid bone structure
|
Body proper of sphenoid
|
Structure of clinoid process of sphenoid bone
|
Sphenoidal crest
|
Sphenoid bone structure
| 3 |
C0925966::articulates_with
|
articulates_with
|
Which anatomic structure articulates with {subj}?
|
C0925966
|
Right lacrimal bone
|
C0015027
|
Ethmoid bone structure
|
Sphenoid bone part
|
Omohyoid muscle structure
|
Bone structure of intermediate cuneiform
|
Ethmoid bone structure
| 3 |
C0038293::articulates_with
|
articulates_with
|
Which anatomic structure articulates with {subj}?
|
C0038293
|
Sternum
|
C0502659
|
Right first costal cartilage
|
Left minor alar cartilage
|
Body of ninth costal cartilage
|
Right lateral nasal cartilage
|
Right first costal cartilage
| 3 |
C0029927::associated_condition_of
|
associated_condition_of
|
For which of the following is {subj} an associated condition?
|
C0029927
|
Ovarian Cysts
|
C0238015
|
Autonomic Dysreflexia
|
Autonomic Dysreflexia
|
Autonomic disorder due to metabolic disorder
|
Diabetic Autonomic Neuropathy
|
Baroreflex failure syndrome
| 0 |
C5848305::associated_condition_of
|
associated_condition_of
|
For which of the following is {subj} an associated condition?
|
C5848305
|
Porphyria (disorder)
|
C4060572
|
Chronic functional constipation
|
Chronic functional constipation
|
Intermittent dysphagia
|
Chronic radiation cystitis
|
Dysfunctional voiding
| 0 |
C0008679::associated_condition_of
|
associated_condition_of
|
For which of the following is {subj} an associated condition?
|
C0008679
|
Chronic disease
|
C0812364
|
Chronic sorrow
|
Organic depression
|
Felt vague
|
Chronic sorrow
|
Mental deficiency
| 2 |
C0030499::associated_etiologic_finding_of
|
associated_etiologic_finding_of
|
For which of the following is {subj} an associated etiologic finding?
|
C0030499
|
Parasitic Diseases
|
C0409572
|
Arthropathy of the ankle and/or foot associated with helminthiasis
|
Other infectious and parasitic diseases with arthropathy of the pelvic region and thigh
|
Arthropathy of the ankle and/or foot associated with helminthiasis
|
Other infectious and parasitic diseases with arthropathy of the lower leg
|
Other infectious and parasitic diseases with arthropathy of the hand
| 1 |
C0011849::associated_etiologic_finding_of
|
associated_etiologic_finding_of
|
For which of the following is {subj} an associated etiologic finding?
|
C0011849
|
Diabetes Mellitus
|
C0271674
|
Asymmetric Diabetic Proximal Motor Neuropathy
|
Chronic Metabolic Polyneuropathy
|
Spinocerebellar Ataxia with Dysmorphism
|
Asymmetric Diabetic Proximal Motor Neuropathy
|
Drug or Chemical Induced Diabetes Mellitus with Neurological Complication with Diabetic Polyneuropathy
| 2 |
C1882062::associated_etiologic_finding_of
|
associated_etiologic_finding_of
|
For which of the following is {subj} an associated etiologic finding?
|
C1882062
|
Neoplastic disease
|
C0730308
|
Melanoma-Associated Retinopathy
|
Advanced Uveal Melanoma
|
Locally Advanced Ocular Melanoma
|
Uveal Class 2 Melanoma
|
Melanoma-Associated Retinopathy
| 3 |
C0021368::associated_morphology_of
|
associated_morphology_of
|
For which of the following is {subj} an associated morphology?
|
C0021368
|
Inflammation
|
C0267508
|
Colitis cystica profunda
|
Colitis cystica profunda
|
Condyloma accuminata recurrent
|
Proctitis fungal
|
Ulcerative (chronic) pancolitis with fistula
| 0 |
C0016665::associated_morphology_of
|
associated_morphology_of
|
For which of the following is {subj} an associated morphology?
|
C0016665
|
Fractures, Ununited
|
C2214361
|
nonunion of fracture of base of first metacarpal of right hand
|
malunion of fracture of shaft of right first metacarpal
|
malunion of fracture of head of right fourth metacarpal
|
nonunion of fracture of base of first metacarpal of right hand
|
malunion of fracture of neck of right fourth metacarpal
| 2 |
C0334044::associated_morphology_of
|
associated_morphology_of
|
For which of the following is {subj} an associated morphology?
|
C0334044
|
Dysplasia
|
C0586351
|
Mild stomach dysplasia
|
Meibomian gland dysfunction
|
Mild stomach dysplasia
|
Pharyngeal dysplasia
|
Mild dysostosis multiplex
| 1 |
C1148575::biological_process_involves_gene_product
|
biological_process_involves_gene_product
|
Which gene product is involved in the biological process of {subj}?
|
C1148575
|
antigen binding
|
C4331804
|
ppUL38 Antibody
|
ppUL38 Antibody
|
Titin Ab
|
LAN Antibody
|
CD41-Bf Ag
| 0 |
C1517880::biological_process_involves_gene_product
|
biological_process_involves_gene_product
|
Which gene product is involved in the biological process of {subj}?
|
C1517880
|
Ligand Binding
|
C1506359
|
KLRD1 protein, human
|
PLEC protein, human
|
LRRTM2 protein, human
|
KLRD1 protein, human
|
AGR3 protein, human
| 2 |
C1148673::biological_process_involves_gene_product
|
biological_process_involves_gene_product
|
Which gene product is involved in the biological process of {subj}?
|
C1148673
|
DNA Binding
|
C1506608
|
FOXA2 protein, human
|
FOXA2 protein, human
|
NPM1 protein, human
|
MUC5AC protein, human
|
CDCP1 protein, human
| 0 |
C1513112::biological_process_is_part_of_process
|
biological_process_is_part_of_process
|
Which larger process is the biological process {subj} a part of?
|
C1513112
|
Membrane Protein Traffic
|
C1514251
|
Post-Translational Regulation
|
positive regulation of protein autoubiquitination
|
eIF2 Regulation Pathway
|
Regulation of Proteolysis
|
Post-Translational Regulation
| 3 |
C1517338::biological_process_is_part_of_process
|
biological_process_is_part_of_process
|
Which larger process is the biological process {subj} a part of?
|
C1517338
|
Negative Regulation of G0 to G1 Transition
|
C1155839
|
Mitotic Cell Cycle
|
Mitotic Cell Cycle
|
generative cell mitosis
|
Negative Regulation of Cytolytic Process
|
Mitotic Spindle Checkpoints
| 0 |
C1519473::biological_process_is_part_of_process
|
biological_process_is_part_of_process
|
Which larger process is the biological process {subj} a part of?
|
C1519473
|
Spleen Development
|
C0678723
|
biological development
|
primary sex determination
|
secondary growth
|
biological development
|
infection cushion formation
| 2 |
C0505647::branch_of
|
branch_of
|
Which of the following is {subj} a branch of?
|
C0505647
|
Muscular branch of lateral branch of posterior ramus of left first thoracic nerve
|
C0505300
|
Lateral branch of posterior ramus of left first thoracic nerve
|
Lateral branch of posterior ramus of left first thoracic nerve
|
Lateral cutaneous branch of medial branch of posterior ramus of right first thoracic nerve
|
Lateral cutaneous branch of medial branch of posterior ramus of right twelfth thoracic nerve
|
Lateral cutaneous branch of medial branch of posterior ramus of left third thoracic nerve
| 0 |
C0923265::branch_of
|
branch_of
|
Which of the following is {subj} a branch of?
|
C0923265
|
Right ophthalmic artery
|
C0226156
|
Structure of right internal carotid artery
|
Structure of right internal carotid artery
|
Tentorial marginal branch of internal carotid artery
|
Structure of left cavernous portion of internal carotid artery
|
Structure of carotid sinus
| 0 |
C0226475::branch_of
|
branch_of
|
Which of the following is {subj} a branch of?
|
C0226475
|
Structure of left posterior tibial artery
|
C0226400
|
Structure of left external iliac artery
|
Structure of right iliac vessel
|
Structure of left external iliac artery
|
Structure of common iliac vein
|
Structure of left popliteal vein
| 1 |
C0013227::causative_agent_of
|
causative_agent_of
|
Which condition is caused by {subj} as an agent?
|
C0013227
|
Pharmaceutical Preparations
|
C0271805
|
Hypothyroidism caused by drug
|
Hypothyroidism in childbirth
|
Hypothyroidism due to iodide trapping defect
|
Severe hypothyroidism
|
Hypothyroidism caused by drug
| 3 |
C0040979::causative_agent_of
|
causative_agent_of
|
Which condition is caused by {subj} as an agent?
|
C0040979
|
trifluoperazine
|
C4075958
|
Retinopathy caused by trifluoperazine
|
Adverse reaction to ipratropium bromide
|
Adverse reaction to chlortetracycline hydrochloride
|
Retinopathy caused by trifluoperazine
|
Adverse reaction to medroxyprogesterone acetate
| 2 |
C0022625::causative_agent_of
|
causative_agent_of
|
Which condition is caused by {subj} as an agent?
|
C0022625
|
ketoconazole
|
C0413464
|
Ketoconazole adverse reaction
|
Adverse reaction to promethazine hydrochloride
|
Adverse reaction to isoprenaline sulphate
|
Ketoconazole adverse reaction
|
Adverse reaction to bezafibrate
| 2 |
C0277542::cause_of
|
cause_of
|
Which of the following is caused by {subj}?
|
C0277542
|
Organic disease present
|
C4064407
|
obsessive-compulsive and related disorder due to another medical condition
|
alcohol dependence with alcohol-induced psychotic disorder with delusions
|
Obsessive compulsive disorder caused by stimulant
|
alcohol abuse with alcohol-induced psychotic disorder with delusions
|
obsessive-compulsive and related disorder due to another medical condition
| 3 |
C4721412::cause_of
|
cause_of
|
Which of the following is caused by {subj}?
|
C4721412
|
Malignant Pancreatic Insulinoma
|
C5229728
|
Hyperinsulinemia due to malignant insulinoma
|
Humoral hypercalcemia of malignancy (disorder)
|
Adult onset non-insulinoma persistent hyperinsulinemic hypoglycemia
|
Idiopathic transient neonatal hyperinsulinemia
|
Hyperinsulinemia due to malignant insulinoma
| 3 |
C0009450::cause_of
|
cause_of
|
Which of the following is caused by {subj}?
|
C0009450
|
Communicable Diseases
|
C0409677
|
Juvenile reactive arthritis triad
|
Juvenile pauciarticular chronic arthritis
|
Juvenile idiopathic arthritis, persistent oligoarthritis
|
Juvenile polyarteritis
|
Juvenile reactive arthritis triad
| 3 |
C0039195::cell_type_or_tissue_affected_by_chemical_or_drug
|
cell_type_or_tissue_affected_by_chemical_or_drug
|
Which cell type or tissue is affected by the chemical or drug {subj}?
|
C0039195
|
Cytotoxic T-Lymphocytes
|
C3891455
|
HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c
|
MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000
|
AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992
|
HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c
|
CMVpp65/gB Plasmid Vaccine ASP0113
| 2 |
C0225336::cell_type_or_tissue_affected_by_chemical_or_drug
|
cell_type_or_tissue_affected_by_chemical_or_drug
|
Which cell type or tissue is affected by the chemical or drug {subj}?
|
C0225336
|
Endothelial Cells
|
C0038880
|
suramin
|
narasin
|
suramin
|
flibanserin
|
procaterol
| 1 |
C0018956::cell_type_or_tissue_affected_by_chemical_or_drug
|
cell_type_or_tissue_affected_by_chemical_or_drug
|
Which cell type or tissue is affected by the chemical or drug {subj}?
|
C0018956
|
Hematopoietic stem cells
|
C0210630
|
filgrastim
|
Lipegfilgrastim only product
|
filgrastim
|
pegfilgrastim-cbqv
|
pegfilgrastim-jmdb
| 1 |
C1174995::chemical_or_drug_has_mechanism_of_action
|
chemical_or_drug_has_mechanism_of_action
|
What is the mechanism of action of the chemical or drug {subj}?
|
C1174995
|
efalizumab
|
C1148575
|
antigen binding
|
protease binding
|
host cell surface receptor binding
|
antigen binding
|
IgG binding
| 2 |
C1831781::chemical_or_drug_has_mechanism_of_action
|
chemical_or_drug_has_mechanism_of_action
|
What is the mechanism of action of the chemical or drug {subj}?
|
C1831781
|
Synthetic Breast Cancer Peptides-Tetanus Toxoid-Montanide ISA-51 Vaccine
|
C1706823
|
Antigen Sensitization
|
Antigen Sensitization
|
CD38-directed Antibody Interactions
|
Anthrax Protective Antigen-directed Antibody Interactions
|
CD86-directed Antibody Interactions
| 0 |
C5432276::chemical_or_drug_has_mechanism_of_action
|
chemical_or_drug_has_mechanism_of_action
|
What is the mechanism of action of the chemical or drug {subj}?
|
C5432276
|
Vibostolimab
|
C1148575
|
antigen binding
|
IgG binding
|
protease binding
|
antigen binding
|
peptide antigen assembly with MHC protein complex
| 2 |
C5448080::chemical_or_drug_has_physiologic_effect
|
chemical_or_drug_has_physiologic_effect
|
What physiologic effect does the chemical or drug {subj} have?
|
C5448080
|
CDK9 Inhibitor GFH009
|
C0017263
|
Gene Expression Regulation
|
Transcriptional Regulation
|
Transcription, Genetic
|
Gene Expression Regulation
|
negative regulation of gene expression
| 2 |
C5206651::chemical_or_drug_has_physiologic_effect
|
chemical_or_drug_has_physiologic_effect
|
What physiologic effect does the chemical or drug {subj} have?
|
C5206651
|
Luminespib Mesylate
|
C1326205
|
Positive Regulation of Apoptosis
|
Positive Regulation of Apoptosis
|
positive regulation of programmed cell death
|
negative regulation of apoptotic cell clearance
|
negative regulation of apoptosome assembly
| 0 |
C3896843::chemical_or_drug_has_physiologic_effect
|
chemical_or_drug_has_physiologic_effect
|
What physiologic effect does the chemical or drug {subj} have?
|
C3896843
|
hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301
|
C1155065
|
T-Cell Activation
|
B-Cell Immune Response Pathway
|
Negative Regulation of Lymphocyte Activation
|
activated T cell proliferation
|
T-Cell Activation
| 3 |
C0023660::chemical_or_drug_is_metabolized_by_enzyme
|
chemical_or_drug_is_metabolized_by_enzyme
|
Which enzyme metabolizes the chemical or drug {subj}?
|
C0023660
|
lidocaine
|
C3887685
|
Cytochrome P450 2D6, human
|
Cytochrome p450 CYP3A43 enzyme
|
Cytochrome p450 CYP2R1 enzyme
|
Cytochrome P450 46A1
|
Cytochrome P450 2D6, human
| 3 |
C0546857::chemical_or_drug_is_metabolized_by_enzyme
|
chemical_or_drug_is_metabolized_by_enzyme
|
Which enzyme metabolizes the chemical or drug {subj}?
|
C0546857
|
chlorpheniramine maleate
|
C1142644
|
cytochrome P450 3A4 protein, human
|
Cytochrome p450 CYP2S1 enzyme
|
cytochrome P-450 CYP1B1
|
cytochrome P450 3A4 protein, human
|
Cytochrome p450 CYP5A1 enzyme
| 2 |
C0063077::chemical_or_drug_is_metabolized_by_enzyme
|
chemical_or_drug_is_metabolized_by_enzyme
|
Which enzyme metabolizes the chemical or drug {subj}?
|
C0063077
|
hydrocortisone acetate
|
C1142644
|
cytochrome P450 3A4 protein, human
|
cytochrome P-450 CYP1B1
|
Cytochrome p450 CYP3A7 enzyme
|
Cytochrome p450 CYP2A13 enzyme
|
cytochrome P450 3A4 protein, human
| 3 |
C0796472::chemotherapy_regimen_has_component
|
chemotherapy_regimen_has_component
|
Which of the following is a component of the chemotherapy regimen {subj}?
|
C0796472
|
Amifostine/Carboplatin/Etoposide/Ifosfamide
|
C0015020
|
amifostine
|
febuxostat
|
dalfampridine
|
amifostine
|
feprazone
| 2 |
C0879517::chemotherapy_regimen_has_component
|
chemotherapy_regimen_has_component
|
Which of the following is a component of the chemotherapy regimen {subj}?
|
C0879517
|
Celecoxib/Selenium
|
C0036581
|
selenium
|
sodium selenate
|
chromium
|
selenium
|
trace elements with selenium
| 2 |
C0280675::chemotherapy_regimen_has_component
|
chemotherapy_regimen_has_component
|
Which of the following is a component of the chemotherapy regimen {subj}?
|
C0280675
|
Cisplatin/Cyclophosphamide/Doxorubicin/Etoposide/Methotrexate/Vincristine
|
C0008838
|
cisplatin
|
Cisplatin liposome
|
Carboplatin only product
|
Citoplatino
|
cisplatin
| 3 |
C0008655::chromosome_involved_in_cytogenetic_abnormality
|
chromosome_involved_in_cytogenetic_abnormality
|
Which chromosome is involved in the cytogenetic abnormality {subj}?
|
C0008655
|
Chromosomes, Human, Pair 13
|
C1515583
|
del(13q21-qter)
|
Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1
|
Chromosome 3, monosomy 3q13
|
del(13q21-qter)
|
Chromosome 14q, partial deletions
| 2 |
C0008665::chromosome_involved_in_cytogenetic_abnormality
|
chromosome_involved_in_cytogenetic_abnormality
|
Which chromosome is involved in the cytogenetic abnormality {subj}?
|
C0008665
|
Chromosomes, Human, Pair 22
|
C5420426
|
NF2 Gene Deletion
|
ARID2 Gene Mutation
|
NF1 Gene Mutation
|
Deleterious NBN Gene Mutation
|
NF2 Gene Deletion
| 3 |
C0008652::chromosome_involved_in_cytogenetic_abnormality
|
chromosome_involved_in_cytogenetic_abnormality
|
Which chromosome is involved in the cytogenetic abnormality {subj}?
|
C0008652
|
Chromosomes, Human, Pair 10
|
C5238354
|
t(10;11)(p12.1;q23.3)
|
PML/RAR alpha (t(15;17)) gene expression
|
Chromosome region Xp22.33 &or Yp11.32 deletion+duplication
|
t(10;11)(p12.1;q23.3)
|
1p & 19q chromosome deletion
| 2 |
C0021034::complex_has_physical_part
|
complex_has_physical_part
|
Which of the following is a physical part of the complex {subj}?
|
C0021034
|
Immunoglobulin Heavy Chains
|
C5444093
|
Immunoglobulin Heavy Constant Mu
|
Immunoglobulin E antigen
|
Immunoglobulin M
|
Linen Antibody.immunoglobulin E
|
Immunoglobulin Heavy Constant Mu
| 3 |
C0033384::complex_has_physical_part
|
complex_has_physical_part
|
Which of the following is a physical part of the complex {subj}?
|
C0033384
|
Procollagen-Proline Dioxygenase
|
C3542409
|
Prolyl 4-Hydroxylase Subunit Alpha-2
|
Dihydrolipoyllysine-Residue Succinyltransferase Component of 2-Oxoglutarate Dehydrogenase Complex, Mitochondrial
|
Prolyl 4-Hydroxylase Subunit Alpha-2
|
Sterol 26-Hydroxylase, Mitochondrial, Human
|
3 Beta-Hydroxysteroid Dehydrogenase/Delta 5-->4-Isomerase Type 2, human
| 1 |
C4723818::complex_has_physical_part
|
complex_has_physical_part
|
Which of the following is a physical part of the complex {subj}?
|
C4723818
|
Canonical BAF Complex
|
C1332367
|
SMARCE1 protein, human
|
SORT1 protein, human
|
SMARCE1 protein, human
|
SCARB1 protein, human
|
ASAP1 protein, human
| 1 |
C0010711::component_of
|
component_of
|
Which of the following contains {subj} as a component?
|
C0010711
|
cytarabine
|
C0280710
|
Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine
|
Cyclophosphamide/Epirubicin/Vincristine Regimen
|
Cyclophosphamide/Daunorubicin/Dexamethasone/Pegaspargase/Vincristine Regimen
|
Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine/R-Verapamil
|
Asparaginase/Cyclophosphamide/Cytarabine/Thioguanine/Vincristine
| 3 |
C0108754::component_of
|
component_of
|
Which of the following contains {subj} as a component?
|
C0108754
|
CD56 Antigens
|
C5188572
|
CD3-CD16+CD56+ cells in unspecified specimen
|
CD45 cells per 100 cells in blood
|
CD20 Cells/100 Cells in Unspecified Specimen
|
CD3-CD16+CD56+ cells in unspecified specimen
|
B-cell CD27 & IgD subsets panel
| 2 |
C0002520::component_of
|
component_of
|
Which of the following contains {subj} as a component?
|
C0002520
|
Amino Acids
|
C0546747
|
Amino acid chromatography
|
Ultracentrifugation
|
Amino acid chromatography
|
Acid fast stain (procedure)
|
Analysis using protein truncation test
| 1 |
C0000970::contained_in
|
contained_in
|
Which of the following contains {subj}?
|
C0000970
|
acetaminophen
|
C2080494
|
acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine
|
atropine / chlorpheniramine / phenylephrine / phenyltoloxamine
|
dexbrompheniramine / dextromethorphan / guaifenesin / phenylephrine
|
acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine
|
chlorpheniramine / guaifenesin / phenylpropanolamine / pseudoephedrine
| 2 |
C0028356::contained_in
|
contained_in
|
Which of the following contains {subj}?
|
C0028356
|
norethindrone
|
C5455339
|
estradiol / norethindrone / relugolix
|
Relugolix / Estradiol / Norethindrone Acetate
|
Drospirenone and estradiol only product
|
estradiol / norethindrone / relugolix
|
dienogest / ethinyl estradiol
| 2 |
C0033798::contained_in
|
contained_in
|
Which of the following contains {subj}?
|
C0033798
|
pseudoephedrine
|
C2929162
|
brompheniramine / dextromethorphan / guaifenesin / pseudoephedrine
|
chlorpheniramine + dextromethorphan + terpin hydrate
|
chlorpheniramine + sodium salicylate + caffeine + dextromethorphan + guaifenesin
|
brompheniramine / dextromethorphan / guaifenesin / pseudoephedrine
|
brompheniramine / guaifenesin / phenylephrine
| 2 |
C0717396::contains
|
contains
|
Which of the following is contained in {subj}?
|
C0717396
|
aluminum hydroxide / mineral oil
|
C0002371
|
aluminum hydroxide
|
aluminum hydroxide / magnesium trisilicate
|
aluminum hydroxide
|
magnesium carbonate hydroxide
|
aluminum hydroxide / silicon dioxide
| 1 |
C0230147::contains
|
contains
|
Which of the following is contained in {subj}?
|
C0230147
|
Superior mediastinum
|
C0925190
|
T4 segment of esophagus
|
T4 segment of esophagus
|
Segment of esophagus
|
Aortic narrowing of esophagus
|
Structure of esophageal gland
| 0 |
C2080527::contains
|
contains
|
Which of the following is contained in {subj}?
|
C2080527
|
acetaminophen / diphenhydramine / guaifenesin / phenylephrine
|
C0000970
|
acetaminophen
|
acetaminophen / dimenhydrinate
|
acetaminophen
|
acetaminophen / piroxicam
|
acetaminophen / styramate
| 1 |
C3883272::contraindicated_class_of
|
contraindicated_class_of
|
For which class is {subj} contraindicated?
|
C3883272
|
dasabuvir sodium monohydrate
|
C0073633
|
ranolazine
|
profenamine
|
robenidine
|
ranolazine
|
vinburnine
| 2 |
C0286738::contraindicated_class_of
|
contraindicated_class_of
|
For which class is {subj} contraindicated?
|
C0286738
|
saquinavir
|
C0012291
|
dihydroergotamine
|
dehydroemetine
|
dihydroergotamine
|
dihydroergotoxine
|
Dihydroergotamine only product in nasal dose form
| 1 |
C5540070::contraindicated_class_of
|
contraindicated_class_of
|
For which class is {subj} contraindicated?
|
C5540070
|
samidorphan L-malate
|
C0242402
|
Opioids
|
Pharmagesic
|
Opioids
|
Sedatives
|
Percogesic
| 1 |
C0030830::contraindicated_with_disease
|
contraindicated_with_disease
|
Which disease contraindicates the use of {subj}?
|
C0030830
|
penicillin G procaine
|
C0013182
|
Drug Allergy
|
Allergy to topical drugs
|
Drug Allergy
|
Allergy to horse protein
|
Allergy to seed
| 1 |
C0851344::contraindicated_with_disease
|
contraindicated_with_disease
|
Which disease contraindicates the use of {subj}?
|
C0851344
|
exemestane
|
C0013182
|
Drug Allergy
|
Allergy to chemicals
|
Allergy to fungus
|
Drug Allergy
|
Allergy to plant
| 2 |
C1883309::contraindicated_with_disease
|
contraindicated_with_disease
|
Which disease contraindicates the use of {subj}?
|
C1883309
|
thioguanine anhydrous
|
C0032961
|
Pregnancy
|
Septuplet pregnancy
|
Pregnancy
|
Single pregnancy
|
Mullerian duct regression
| 1 |
C5419220::cytogenetic_abnormality_involves_chromosome
|
cytogenetic_abnormality_involves_chromosome
|
Which chromosome is involved in the cytogenetic abnormality {subj}?
|
C5419220
|
Rearrangement of 12p13.2
|
C0008654
|
Chromosomes, Human, Pair 12
|
Chromosomes, Human, 21-22 and Y
|
Chromosomes, Human, Pair 12
|
condensed chromosome, centromeric region
|
Chromosomes, Human, 13-15
| 1 |
C1515648::cytogenetic_abnormality_involves_chromosome
|
cytogenetic_abnormality_involves_chromosome
|
Which chromosome is involved in the cytogenetic abnormality {subj}?
|
C1515648
|
i(17q)
|
C0008659
|
Chromosomes, Human, Pair 17
|
polytene chromosome chromocenter
|
chromosome, centromeric region
|
Chromosomes
|
Chromosomes, Human, Pair 17
| 3 |
C5446674::cytogenetic_abnormality_involves_chromosome
|
cytogenetic_abnormality_involves_chromosome
|
Which chromosome is involved in the cytogenetic abnormality {subj}?
|
C5446674
|
CHIC2 Gene Deletion
|
C0008667
|
Chromosomes, Human, Pair 4
|
chromosome, telomeric repeat region
|
Chromosome Territory
|
Chromosomes, Human, Pair 4
|
Chromosome band
| 2 |
C0018099::default_inpatient_classification_of
|
default_inpatient_classification_of
|
For which of the following is {subj} the default inpatient classification?
|
C0018099
|
Gout
|
C2894121
|
Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi)
|
chronic gout of foot without tophus due to renal impairment
|
Chronic gout of elbow without tophus caused by drug
|
Primary chronic gout without tophus of vertebra
|
Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi)
| 3 |
C0024305::default_inpatient_classification_of
|
default_inpatient_classification_of
|
For which of the following is {subj} the default inpatient classification?
|
C0024305
|
Lymphoma, Non-Hodgkin
|
C2853810
|
Follicular Lymphoma Grade III, Unspecified, Lymph Nodes of Axilla and Upper Limb
|
Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
|
Follicular Lymphoma Grade III, Unspecified, Lymph Nodes of Axilla and Upper Limb
|
Ann Arbor Stage III Grade 3 Follicular Lymphoma
|
Ann Arbor Stage III Grade 2 Follicular Lymphoma
| 1 |
C5225826::default_inpatient_classification_of
|
default_inpatient_classification_of
|
For which of the following is {subj} the default inpatient classification?
|
C5225826
|
Pressure ulcer of skin
|
C2888559
|
Pressure injury of right heel stage IV
|
Pressure injury of right heel stage IV
|
Pressure injury of right lower leg stage IV
|
Pressure injury of left foot stage II
|
Pressure injury of right foot stage III
| 0 |
C5225867::default_outpatient_classification_of
|
default_outpatient_classification_of
|
For which of the following is {subj} the default outpatient classification?
|
C5225867
|
Crystal arthropathies (excluding gout)
|
C2893561
|
familial chondrocalcinosis wrist
|
familial chondrocalcinosis wrist
|
chondrocalcinosis of foot
|
familial chondrocalcinosis hip
|
chondrocalcinosis of hip
| 0 |
C4041080::default_outpatient_classification_of
|
default_outpatient_classification_of
|
For which of the following is {subj} the default outpatient classification?
|
C4041080
|
Neurocognitive Disorders
|
C5674995
|
mild neurocognitive disorder due to known physiological condition with behavioral disturbance
|
Mental and behavioral disorders due to use of cannabinoids, withdrawal state with delirium
|
mild neurocognitive disorder due to known physiological condition with behavioral disturbance
|
Severe mental retardation with the statement of no, or minimal, impairment of behavior
|
Other mental retardation without mention of impairment of behavior
| 1 |
C5225999::default_outpatient_classification_of
|
default_outpatient_classification_of
|
For which of the following is {subj} the default outpatient classification?
|
C5225999
|
Complication of genitourinary device, implant or graft, subsequent encounter
|
C4270236
|
Other mechanical complication of indwelling urethral catheter, subsequent encounter
|
Obstruction of urethral urinary catheter
|
inflammatory reaction due to indwelling urinary catheter
|
mechanical complication of urinary electronic stimulator device breakdown
|
Other mechanical complication of indwelling urethral catheter, subsequent encounter
| 3 |
C3469128::defining_characteristic_of
|
defining_characteristic_of
|
For which of the following is {subj} a defining characteristic?
|
C3469128
|
personal growth
|
C0018235
|
Grief reaction
|
Excitedness
|
Conscious mind
|
Overlearning
|
Grief reaction
| 3 |
C4061436::defining_characteristic_of
|
defining_characteristic_of
|
For which of the following is {subj} a defining characteristic?
|
C4061436
|
Excessive self-blame
|
C4060542
|
Impaired mood regulation
|
Impaired mood regulation
|
Executive dysfunction
|
Alteration in memory
|
Impaired psychomotor development
| 0 |
C0242528::defining_characteristic_of
|
defining_characteristic_of
|
For which of the following is {subj} a defining characteristic?
|
C0242528
|
Azotemia
|
C0546817
|
Hypervolemia (finding)
|
Dilutional hyponatremia
|
Hypervolemia (finding)
|
Hypovolemic Shock
|
Lymphedema (lower limb)
| 1 |
C0013182::definitional_manifestation_of
|
definitional_manifestation_of
|
For which of the following is {subj} a definitional manifestation?
|
C0013182
|
Drug Allergy
|
C0571315
|
Anti-infective nasal preparations allergy
|
Allergy to food additive
|
Allergic rhinitis caused by feathers
|
Anti-infective nasal preparations allergy
|
Allergic rhinitis due to food
| 2 |
C0221395::definitional_manifestation_of
|
definitional_manifestation_of
|
For which of the following is {subj} a definitional manifestation?
|
C0221395
|
Erythropenia
|
C2919522
|
Congenital hemolytic uremic syndrome
|
Familial Atypical Hemolytic Uremic Syndrome
|
Congenital uremia
|
Congenital methemoglobinemia (due to enzyme deficiency)
|
Congenital hemolytic uremic syndrome
| 3 |
C0349231::definitional_manifestation_of
|
definitional_manifestation_of
|
For which of the following is {subj} a definitional manifestation?
|
C0349231
|
Phobic anxiety disorder
|
C0270587
|
Generalized social phobia
|
Generalized social phobia
|
Inhalant-induced psychotic disorder with delusions
|
animal type phobia
|
Psychotic disorder caused by anxiolytic
| 0 |
C0332996::direct_morphology_of
|
direct_morphology_of
|
Which of the following has {subj} as its direct morphology?
|
C0332996
|
Persistent embryonic structure
|
C0198511
|
Excision of omphalomesenteric duct
|
Excision of thyroglossal tract
|
Excision of omphalomesenteric duct
|
Excision of colonic pouch
|
Incision of mesentery
| 1 |
C0559494::direct_morphology_of
|
direct_morphology_of
|
Which of the following has {subj} as its direct morphology?
|
C0559494
|
Intestinal stoma
|
C0192810
|
Dilation of intestinal stoma
|
dilation of ileum with intraluminal device
|
Jejunoscopy and insertion of tube prosthesis
|
Creation of proctostomy
|
Dilation of intestinal stoma
| 3 |
C5848091::direct_morphology_of
|
direct_morphology_of
|
Which of the following has {subj} as its direct morphology?
|
C5848091
|
Viral wart of skin and/or mucous membrane caused by human papillomavirus
|
C2959416
|
Cauterization of wart of pinna
|
Cauterization of forefoot
|
Drainage of petrous apex of mastoid
|
Cauterization of external ear
|
Cauterization of wart of pinna
| 3 |
C0031354::direct_procedure_site_of
|
direct_procedure_site_of
|
Which procedure directly targets the site {subj}?
|
C0031354
|
Pharyngeal structure
|
C0192253
|
Transplantation of pharyngeal tissue
|
Laryngeal reinnervation by neuromuscular pedicle
|
Injection of neurolytic substance to glossopharyngeal nerve
|
Transplantation of pharyngeal tissue
|
Reconstruction of zygomatic arch and glenoid fossa with bone and cartilage (includes obtaining autografts)
| 2 |
C1276274::direct_procedure_site_of
|
direct_procedure_site_of
|
Which procedure directly targets the site {subj}?
|
C1276274
|
Structure of soft tissues of neck
|
C2153057
|
soft tissue mobilization of anterior aspect of neck
|
scar tissue mobilization of deltoid region of right shoulder
|
scar tissue mobilization of right thigh
|
scar tissue mobilization of left anterior aspect of chest
|
soft tissue mobilization of anterior aspect of neck
| 3 |
C0225066::direct_procedure_site_of
|
direct_procedure_site_of
|
Which procedure directly targets the site {subj}?
|
C0225066
|
Collateral ulnar ligament of elbow
|
C4277652
|
Ulnar Collateral Ligament Reconstruction
|
Open treatment of distal tibiofibular joint (syndesmosis) disruption, includes internal fixation, when performed
|
Open treatment of tarsometatarsal joint dislocation, includes internal fixation, when performed
|
closed treatment of humeral greater tuberosity fracture
|
Ulnar Collateral Ligament Reconstruction
| 3 |
C0334498::disease_excludes_abnormal_cell
|
disease_excludes_abnormal_cell
|
Which abnormal cell type is specifically excluded in the definition of the disease {subj}?
|
C0334498
|
Serous adenofibroma
|
C1518246
|
Malignant Stromal Cell
|
Malignant Cutaneous Basal Cell
|
Malignant Squamoid Cell
|
Neoplastic Melanocyte
|
Malignant Stromal Cell
| 3 |
C1336013::disease_excludes_abnormal_cell
|
disease_excludes_abnormal_cell
|
Which abnormal cell type is specifically excluded in the definition of the disease {subj}?
|
C1336013
|
Small Lymphocytic Lymphoma with Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
|
C0085133
|
Reed-Sternberg Cells
|
Leukemic Natural Killer Cell
|
Reed-Sternberg Cells
|
Epithelioid Cells
|
Spindle Melanocyte
| 1 |
C1711320::disease_excludes_abnormal_cell
|
disease_excludes_abnormal_cell
|
Which abnormal cell type is specifically excluded in the definition of the disease {subj}?
|
C1711320
|
signet ring cell carcinoma of appendix
|
C1514101
|
Neoplastic Squamous Cell
|
Neoplastic Myoepithelial Cell
|
Undifferentiated Neoplastic Blast
|
Neoplastic Melanocyte
|
Neoplastic Squamous Cell
| 3 |
C4744758::disease_excludes_cytogenetic_abnormality
|
disease_excludes_cytogenetic_abnormality
|
Which cytogenetic abnormality is specifically excluded in the disease {subj}?
|
C4744758
|
Thyroid Gland Lymphangioma
|
C1517995
|
Loss of Chromosome 9q
|
Loss of Chromosome 1q
|
Loss of Chromosome 4q
|
Loss of Chromosome 17p
|
Loss of Chromosome 9q
| 3 |
C5206834::disease_excludes_cytogenetic_abnormality
|
disease_excludes_cytogenetic_abnormality
|
Which cytogenetic abnormality is specifically excluded in the disease {subj}?
|
C5206834
|
Benign Parapharyngeal Neoplasm
|
C1517995
|
Loss of Chromosome 9q
|
Loss of Chromosome 22q
|
Loss of Chromosome 6p
|
Loss of Chromosome 8p
|
Loss of Chromosome 9q
| 3 |
C2826148::disease_excludes_cytogenetic_abnormality
|
disease_excludes_cytogenetic_abnormality
|
Which cytogenetic abnormality is specifically excluded in the disease {subj}?
|
C2826148
|
Myelodysplastic/Myeloproliferative Neoplasm Post Cytotoxic Therapy
|
C1515809
|
t(9;22)(q34.1;q11.2)
|
t(10;11)(q21.3;q23.3)
|
t(9;22)(q34.1;q11.2)
|
t(2;22)(q33.3;q12)
|
t(11;19)(q23.3;p13.3)
| 1 |
C4727078::disease_excludes_finding
|
disease_excludes_finding
|
Which finding is specifically excluded in the diagnosis of disease {subj}?
|
C4727078
|
Advanced Synovial Sarcoma
|
C0277565
|
Local disease
|
Severe infection
|
Local disease
|
Soft tissue swelling
|
Tumour inflammation
| 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.